{"name":"Remix Therapeutics","slug":"remix-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxPNGh0TUZVdlJ2Q3czZWhncEVkQkI1ZGdHdFpmMFJIbGg4V0pNb3V1WTBHY19ibS1MeGFFRzVkX2RSeWFfTUhfRVlVR0I0Q2w3Vk9ETE1Qb3FObXVwZll4R0l4c0xObnViYjNHNWdoQzZ1RWtDQW02SzNVdDNxQXkyTlBMTnlpN0FkaEtRd25LUGJHZVBjc3kxVnpobmdWTUR4UFptN3VjNHFRMWxCOW83SjJJSjZtbW5lN1FVRlFpQkZqbVRpRUczUkpTS0Q5U2M5YkdKcFFfWVFnejE1NGhWM0NHVGxJMXVwX2JKMExmR0Z1Sjc4VHowLUdzclN0OU1uaFlKekxJYzRaVEF1d1NDMEUwMmh2XzE3cHc2RGZHT1hJcE9hbE45SXFuSXlBalU5dllxQWxjVmVqV2FTeVNzaFFn?oc=5","date":"2026-03-19","type":"regulatory","source":"GlobeNewswire","summary":"Remix Therapeutics Granted FDA Fast Track Designation for - GlobeNewswire","headline":"Remix Therapeutics Granted FDA Fast Track Designation for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNdV9QM0tqbmlUQU5CWlk3ZkpTaDdRaVMyNGFBa0NUUFZJOTdvNDVGaUJxUzVtZTloMnN1Vnd0bDJVUFNGLW9mZ3ZWMzdWNkhZdzZFUTRnUFh5V0U3Z05rcUZMTWNkTG4zdm9nLWhyWVZZNHduakRuOENhbjRvV2piNW1md3haeFItQ09qTHJPa2tUZDZCdS1veA?oc=5","date":"2026-01-09","type":"pipeline","source":"Fierce Biotech","summary":"Former Roche oncology head turns to Tubulis—Chutes & Ladders - Fierce Biotech","headline":"Former Roche oncology head turns to Tubulis—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQRVpBZ0hUbVI3SUh4RW0wMWNwX3ZpM1Q2YWRXcUQwOXJDdDBEZ0VtRjVrc3ppZFhLNmVDdkRJelhzdnI1MXNjaDVhOS1iVlFNR0dRSlNrQjJ3Z0IxWktLVEpza09LbHJpdFh6aFZ4bTF6RldtZzZmUldMTGJzUnN6OGdPc19kRzc0U1FDSHM0S3BXOEt5TG1TMEE0ejVyak9tMzlDNjFoa0gyYngxYVY5YXFSaElZSnZ5THFDbFJ3VGowMVFoWFBZUzY0T2lWTkQtTjRIOGJiYkRKckhWNEdB?oc=5","date":"2026-01-06","type":"pipeline","source":"GlobeNewswire","summary":"Remix Therapeutics Appoints Mythili Koneru, MD, PhD, as Chief Medical Officer - GlobeNewswire","headline":"Remix Therapeutics Appoints Mythili Koneru, MD, PhD, as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOZkFrRU5xLUpDVmd2aFJ4VEN6QUJkWmcxck1sdUE2UG56dU9zeUhxREgtcDQ5dGxWc203X0pSTm1tcWNPdGFsZ2NpaHhxVmx0SklMa3l2TFRqWkd2blZUcmZBSHNJTzhKWWxxdUtiZkladlNYYjZtNE1kYzRLTEpVeGFrajB1d0pJejNaeE9wUnRIVUcwSFVhLQ?oc=5","date":"2025-12-09","type":"pipeline","source":"cen.acs.org","summary":"HotHouse launches to remix plant compound biosynthesis for pharma - cen.acs.org","headline":"HotHouse launches to remix plant compound biosynthesis for pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1WQWVKSGRjX1A1eG1yeklaNEpnaU9wamFFa1h0YmlRMEV6YkpUT2FMNkVIWW1ieF9OcndpZGFLbDJyWERoSmZJeks3VC1nNGlmOU5IRFRBVTZiN2tMREVEbXp1eDhrM1E5MHdIZV9IQ0g?oc=5","date":"2025-11-11","type":"pipeline","source":"Labiotech.eu","summary":"Boston’s biotech scene is booming: meet 14 biotech companies to watch in 2025 - Labiotech.eu","headline":"Boston’s biotech scene is booming: meet 14 biotech companies to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPMWdTR3F2TUloNkVHa213MFBjY3J0ZmdjVkVWMTNNNzQzaGVBQ1FpbW1ldzhTak14MWJNSmVPT1RJcldESXJVWThldlhfMThZQmFMVnNvU2xMWFJDNzBUeEVpZlBZSTMta3lJUENZMzI4cmJDU2ZJclFZc3pnU3M5NlQtb3oyMTlwNjVnM3pweFgtVG5CZXlJ?oc=5","date":"2025-08-18","type":"pipeline","source":"Fierce Biotech","summary":"Merck KGaA swoops into Skyhawk neurological disease pact worth up to $2B - Fierce Biotech","headline":"Merck KGaA swoops into Skyhawk neurological disease pact worth up to $2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPWjdqZmJMNmVvTXR0eXVlX20zWTByclN2TEpET01wMGgwekVnRTU2NnJqY1VEZU9kVC1PcjQ0LTZvRTFfQ2ZkMmpGWnZpUWFlUi1iUDBEbUlwSDh0Ym1iZlRmMER0Y3IzQWYxcGtsUy00UU5xem1QUy1HS3Uzdm1SM3VxS3dlSXVYVzZzM2RjWnF0WG9SMVBTX1hGS0xDdmJITExZLS1zOVpoNnZKT2xyeDJSSDg2aGZXWmJubkwwcG9YQzVkckJSeS11eERIdlZ0TTJkbGtWOS1OSXB4MXM1Q0JablBNRjhhMm0wMjg3ZWoyNkVqamNxYWpvNzZ5NkdxZjU2M3VCZTVWU1o5czZORGVuV1dac1Y3MUMxWTlYdWNrYnc?oc=5","date":"2024-01-03","type":"deal","source":"PR Newswire","summary":"Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing - PR Newswire","headline":"Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNYXFKQ0Z5SFJ6di1NNkZHMFRuVVZZWWE5OURMYW8xR2lKTUlIU2Z0ekU2c3UycTQwd1dSQ3BVNWNvdVJrOWdVendwZkU0U2pFakNJNU5NM0JJRlM3cVptelp6WThmZm5wUHdiVHE3NVRFLUswNmRnR01yMEJuN3dia2FkREIyR0FSRnF3?oc=5","date":"2024-01-03","type":"pipeline","source":"BioPharma Dive","summary":"Roche joins startup Remix in bet on another way to drug RNA - BioPharma Dive","headline":"Roche joins startup Remix in bet on another way to drug RNA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNMEczS3VwOGcyUXduaEhVVGZ4U3R3YWhRV1lodmhMOVR0dE5PMmk3TWFERTg0aWVlWERmdFc0UF9OWmxkdUtFRjBhbTE4MEF4MVcyVVYzcnlLaVVPMzhsOVR5RlhrQTZRUldrdE5sLTE0RmVTTms0OS1xNEtINnk0aEhoNW94VFcwV2l2Ri1Md2EwdE0tYnpMb085ejNkcExwYlF4dE1xSkFDUDZNMWx2UUFEZHJwTHJjRWp4Z3JDN2EwMWtiNjk4aGZsTEZpeUVEN0NzNXlKclFVcHlHc0FQeXpseTU2VU1raV82QndTSGE3aGdFWFNYdHBHQl9KNWtrNHU3Qm95b0VjRzRYYy10clpuRWFpTmtuWHNGX2Z2eWVpcTdXZ0pmb3RrTFhoT2VWd01UUUVnT0E?oc=5","date":"2022-02-17","type":"regulatory","source":"PR Newswire","summary":"Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing - PR Newswire","headline":"Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQNFBibzFNZE8zQXpIM0xYQXVPSUtuTW9ubDJGOUpiRHgzTFlNdHhNVzNKa2lpU1dEdzg0dzh5WEZ0LUxOMmhfcnMzWmpCenF6TmZ0YWQyTVpqNjNVVTZPREtOalAzeFctdUttWU1vREI2VFdkNDBVTDJSNklDQUJUYkJ1c05xUDhKdmE5YnZZNWtjZDVpZkpQWUhCekF4b21o?oc=5","date":"2022-02-17","type":"deal","source":"BioPharma Dive","summary":"J&J to explore RNA reprogramming with Remix research deal - BioPharma Dive","headline":"J&J to explore RNA reprogramming with Remix research deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOZWd3SkRMb3dLcnNDd041Wld3bHotbzYtTFVyUmZFbHJYQmtFWnRwSy15RXBER2ZhMXpZd1NmbkVrMGhIQlZrV1FUTHpoNndYRmFzRmtuZGlxVmY4MGxPd1pJOUZYQjZYMzA4eXdvZ0tZNzR4MGdtZVlDR19hMWdCcWVwN3dWTEcwZnU1b1BPejlFT0VuUVRPLXFxdzJ2XzR5cFJna1U0SUVSMk5jbzlTTGRiNzA5S1JoUkxPWmZuQ2ZXZGNVSlBHcWpvZzNub2JuUWJQdEVKay1aM29JVS1Md0dOb1lWMDR5ZGxfVF9VSnVKUWxiaTNvUE5BMEQ1SmJUaGdFWTBEMkVGeFlhRDY4?oc=5","date":"2020-12-08","type":"pipeline","source":"PR Newswire","summary":"Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing - PR Newswire","headline":"Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Pro","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}